Literature DB >> 7547506

Rapid activation and down-regulation of protein kinase C alpha in 12-O-Tetradecanoylphorbol-13-acetate-induced differentiation of human rhabdomyosarcoma cells.

M Bouché1, F Zappelli, M Polimeni, S Adamo, W C Wetsel, M I Senni, M Molinaro.   

Abstract

Human rhabdomyosarcoma RD cells express the myogenic regulatory factors MyoD and myogenin but differentiate spontaneously very poorly. Prolonged treatment of RD cells with the protein kinase C (PKC) activator 12-O-tetradecanoylphorbol-13-acetate (TPA) induces growth arrest and myogenic differentiation as shown by the accumulation of alpha-actin and myosin light and heavy chains, without affecting the expression of MyoD and myogenin. In this study, we show that short-term phorbol ester treatment of the cultures is sufficient to trigger myogenic differentiation but not growth arrest. Furthermore, PKC inhibitors, such as staurosporine or calphostin C, prevent TPA-induced differentiation but not cell growth arrest. These data suggest that the two events are mediated by different pathways; a possible interpretation is that the activation of one or more PKC isoforms mediates the induction of differentiation, whereas the down-regulation of the same or different isoforms mediates the growth arrest. To address the mechanism whereby TPA affects cell growth and differentiation in RD cells, we first analyzed PKC isoenzyme distribution. We found that RD cells express the alpha, beta 1, gamma, and sigma PKC isoenzymes. Only the alpha isoform is exclusively found in the soluble fraction, but it translocates to the membrane fraction within 5 min of TPA treatment and is completely down-regulated after 6 h. The other isoenzymes are found associated to both the soluble and the particulate fractions and are down-regulated after long-term TPA treatment. By immunofluorescence analysis, we show that the PKC alpha down-regulation is specific for those cells that respond to TPA by activating the muscle phenotype. We propose that TPA-induced differentiation in RD cells is mediated by the transient activation of PKC alpha, which activates some of the intracellular events that are necessary for MyoD and myogenin transacting activity and for the induction of terminal differentiation of RD cells. By contrast, the constitutively active beta 1 and sigma are responsible for the maintenance of cell growth, and their down-regulation is responsible for long-term TPA-induced cell growth arrest.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7547506

Source DB:  PubMed          Journal:  Cell Growth Differ        ISSN: 1044-9523


  6 in total

1.  Induction of terminal differentiation by constitutive activation of p38 MAP kinase in human rhabdomyosarcoma cells.

Authors:  P L Puri; Z Wu; P Zhang; L D Wood; K S Bhakta; J Han; J R Feramisco; M Karin; J Y Wang
Journal:  Genes Dev       Date:  2000-03-01       Impact factor: 11.361

2.  The induction of senescence-like growth arrest by protein kinase C-activating diterpene esters in solid tumor cells.

Authors:  Sharon A Mason; Sarah-Jane Cozzi; Carly J Pierce; Sandra J Pavey; Peter G Parsons; Glen M Boyle
Journal:  Invest New Drugs       Date:  2009-07-28       Impact factor: 3.850

3.  Protein kinase C iota as a therapeutic target in alveolar rhabdomyosarcoma.

Authors:  K Kikuchi; A Soundararajan; L A Zarzabal; C R Weems; L D Nelon; S T Hampton; J E Michalek; B P Rubin; A P Fields; C Keller
Journal:  Oncogene       Date:  2012-02-20       Impact factor: 9.867

4.  Enzastaurin inhibits ABCB1-mediated drug efflux independently of effects on protein kinase C signalling and the cellular p53 status.

Authors:  Martin Michaelis; Florian Rothweiler; Nadine Löschmann; Mohsen Sharifi; Taravat Ghafourian; Jindrich Cinatl
Journal:  Oncotarget       Date:  2015-07-10

5.  Induction of Myogenic Differentiation Improves Chemosensitivity of Chemoresistant Cells in Soft-Tissue Sarcoma Cell Lines.

Authors:  Lucy E Dawson; Luca D'Agostino; Abraham A Hakim; Richard D Lackman; Spencer A Brown; Richard B Sensenig; Zeus A Antonello; Igor I Kuzin
Journal:  Sarcoma       Date:  2020-03-26

6.  The role of the cullin-5 e3 ubiquitin ligase in the regulation of insulin receptor substrate-1.

Authors:  Christine Zhiwen Hu; Jaswinder K Sethi; Thilo Hagen
Journal:  Biochem Res Int       Date:  2012-12-09
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.